Remove Consumption Remove Epilepsy Remove White Paper
article thumbnail

What will unrestricted access to Medicinal Cannabis look like in Australia?

MGC Pharma

In 2016, we released a white paper in partnership with the University of Sydney that showed, if unrestricted, there would be a demand for roughly 404.7 kg of THC per annum for Epilepsy, MS and HIV/Aids sufferers alone. kg of CBD and 163.7

Access 100
article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

This white paper offers a primer to the complex and confusing global cannabis industry as it stands today. But the global legal landscape is confusing and constantly evolving, making it essential for people and businesses around the world to secure strong legal representation. This is true even if the CBD comes from industrial hemp.

Law 40